Lista de obras -

A retrospective analysis to identify predictors of COPD-related rehospitalization

artículo científico publicado en 2016

A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy.

artículo científico publicado en 2017

Assessing disparities in the receipt of inhaled corticosteroid prescriptions for asthma by Hispanic and non-Hispanic white patients.

artículo científico publicado en 2015

Assessment of components included in published societal perspective or QALY outcome economic analyses for antiepileptic drug treatment in chronic epilepsy

artículo científico publicado en 2018

Budesonide/formoterol therapy: effective and appropriate use in asthma and chronic obstructive pulmonary disease

scientific article published on 27 January 2020

Chronic pain and pain medication use in chronic obstructive pulmonary disease. A cross-sectional study.

artículo científico publicado en 2013

Clinical and economic outcomes in an observational study of COPD maintenance therapies: multivariable regression versus propensity score matching

artículo científico publicado en 2012

Clinical factors, including All Patient Refined Diagnosis Related Group severity, as predictors of early rehospitalization after COPD exacerbation.

artículo científico publicado en 2015

Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease

scientific article published on 01 March 2020

Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease

artículo científico publicado en 2010

Comparative effectiveness of budesonide/formoterol and fluticasone/salmeterol for COPD management

artículo científico publicado en 2011

Comparisons of Food and Drug Administration and European Medicines Agency risk management implementation for recent pharmaceutical approvals: report of the International Society for Pharmacoeconomics and outcomes research risk benefit management wor

artículo científico publicado en 2012

Development of a modified BODE index as a mortality risk measure among older adults with and without chronic obstructive pulmonary disease

artículo científico publicado en 2013

Economic burden of chronic bronchitis in the United States: a retrospective case-control study ⬇️

artículo científico publicado el 13 de enero de 2011

Economic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies.

artículo científico publicado en 2016

Effect of combination fluticasone propionate and salmeterol or inhaled corticosteroids on asthma-related outcomes in a Medicare-eligible population.

artículo científico publicado en 2012

Enteric illness risks before and after water treatment improvements.

artículo científico publicado en 2009

How clean must our drinking water be: the importance of protective immunity.

artículo científico publicado en 2005

Laboratory safety monitoring of chronic medications in ambulatory care settings

artículo científico publicado en 2005

Management of asthma and chronic obstructive pulmonary disease with combination inhaled corticosteroids and long-acting β-agonists: a review of comparative effectiveness research.

artículo científico publicado en 2014

New clinical insights into chronic obstructive pulmonary disease and their implications for pharmacoeconomic analyses

artículo científico publicado en 2012

Nutrition status, bone mass density, and selective serotonin reuptake inhibitors

artículo científico publicado en 2018

Outpatient Complex Case Management: Health System-Tailored Risk Stratification Taxonomy to Identify High-Cost, High-Need Patients

article

Probabilistic data linkage: a case study of comparative effectiveness in COPD.

artículo científico publicado en 2013

Real-World Evidence: Bridging Gaps in Evidence to Guide Payer Decisions

artículo científico publicado en 2020

Rural definition of health: a systematic literature review.

artículo científico publicado en 2015

Subscriber continuity in health insurance plans: factors associated with reenrollment and coverage changes

artículo científico publicado en 2020

Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists

scientific article published on 30 September 2005

The epidemiology, diagnosis, and cost of dyspepsia and Helicobacter pylori gastritis: a case-control analysis in the Southwestern United States.

artículo científico publicado en 2012

The impact of chronic pain on direct medical utilization and costs in chronic obstructive pulmonary disease

artículo científico publicado en 2015

Use of midlevel practitioners to achieve labor cost savings in the primary care practice of an MCO.

artículo científico publicado en 2004

Lista de obras de

A retrospective analysis to identify predictors of COPD-related rehospitalization

A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy.

Assessing disparities in the receipt of inhaled corticosteroid prescriptions for asthma by Hispanic and non-Hispanic white patients.

Assessment of components included in published societal perspective or QALY outcome economic analyses for antiepileptic drug treatment in chronic epilepsy

Budesonide/formoterol therapy: effective and appropriate use in asthma and chronic obstructive pulmonary disease

Chronic pain and pain medication use in chronic obstructive pulmonary disease. A cross-sectional study.

Clinical and economic outcomes in an observational study of COPD maintenance therapies: multivariable regression versus propensity score matching

Clinical factors, including All Patient Refined Diagnosis Related Group severity, as predictors of early rehospitalization after COPD exacerbation.

Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease

Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease

Comparative effectiveness of budesonide/formoterol and fluticasone/salmeterol for COPD management

Comparisons of Food and Drug Administration and European Medicines Agency risk management implementation for recent pharmaceutical approvals: report of the International Society for Pharmacoeconomics and outcomes research risk benefit management wor

Development of a modified BODE index as a mortality risk measure among older adults with and without chronic obstructive pulmonary disease

Economic burden of chronic bronchitis in the United States: a retrospective case-control study ⬇️

Economic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies.

Effect of combination fluticasone propionate and salmeterol or inhaled corticosteroids on asthma-related outcomes in a Medicare-eligible population.

Enteric illness risks before and after water treatment improvements.

How clean must our drinking water be: the importance of protective immunity.

Laboratory safety monitoring of chronic medications in ambulatory care settings

Management of asthma and chronic obstructive pulmonary disease with combination inhaled corticosteroids and long-acting β-agonists: a review of comparative effectiveness research.

New clinical insights into chronic obstructive pulmonary disease and their implications for pharmacoeconomic analyses

Nutrition status, bone mass density, and selective serotonin reuptake inhibitors

Outpatient Complex Case Management: Health System-Tailored Risk Stratification Taxonomy to Identify High-Cost, High-Need Patients

Probabilistic data linkage: a case study of comparative effectiveness in COPD.

Real-World Evidence: Bridging Gaps in Evidence to Guide Payer Decisions

Rural definition of health: a systematic literature review.

Subscriber continuity in health insurance plans: factors associated with reenrollment and coverage changes

Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists

The epidemiology, diagnosis, and cost of dyspepsia and Helicobacter pylori gastritis: a case-control analysis in the Southwestern United States.

The impact of chronic pain on direct medical utilization and costs in chronic obstructive pulmonary disease

Use of midlevel practitioners to achieve labor cost savings in the primary care practice of an MCO.